Skip to main content

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Introduction

U.S. District Judge Edward G. Smith dismissed a plaintiff's claims over defective Zimmer prosthetic hip implant stating she failed to file the case within the two-year statute of limitations.

The plaintiff underwent total hip surgery in 2011 when she was implanted with Zimmer M/L Taper Kinectiv Stem and Neck (the “Kinectiv”) with a Versys Femoral Head (the “Versys Head”), collectively referred to as Zimmer Device. She eventually got it removed in 2015 after experiencing metallosis, which is an adverse local tissue reaction allegedly due to the implant. She filed a lawsuit in February 2017 against the hip implant maker. The Pennsylvania jury stated that she was late by just a few days in filing the case.

Zimmer lawsuits filed across the U.S. claim that the Zimmer M/L Taper Hip Prosthesis and Zimmer VerSys Hip femoral head are defectively designed,  pose major health risks when paired together, and have a tendency to corrode and leave metal pieces inside the body often needing the device to be removed.

Zimmer Durom Hip Cup lawsuits were centralized on June 9, 2010, in the U.S District of New Jersey before Judge Susan D. Wigenton as multidistrict litigation, MDL No. 2158 (In Re: Zimmer Durom Hip Cup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!